Update: Allarity Therapeutics Receives Approximately SEK 23.3 Million (US $2.7 Million) from Subscription to Warrants of Series ALLR TO 2 and TO 3
- Subscription isapproximately 9.5percent of total outstanding TO 3 warrants
- Allaritys Chairman of the Board and largest shareholder (Sass & Larsen ApS) participated in the subscription
Press Release
Hørsholm, Denmark(September15,2021) CORRECTION: The press…
